The DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
Breaking barriers to novel analgesic drug development
Open accessAbstract
Acute and chronic pain complaints, although common, are generally poorly served by existing therapies. This unmet clinical need reflects a failure to develop novel classes of analgesics with superior efficacy, diminished adverse effects and a lower abuse liability than those currently available. Reasons for this include the heterogeneity of clinical pain conditions, the complexity and diversity of underlying pathophysiological mechanisms, and the unreliability of some preclinical pain models. However, recent advances in our understanding of the neurobiology of pain are beginning to offer opportunities for developing novel therapeutic strategies and revisiting existing targets, including modulating ion channels, enzymes and G-protein-coupled receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–266 of 266
Emerging potassium channel targets for the treatment of pain
Tsantoulas, C. (2015) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000131 · Cited by 69
AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions
Paice, J. A., Mulvey, M. R., Bennett, M., Dougherty, P. M., Farrar, J. T., Mantyh, P. W., Miaskowski, C. A., Schmidt, B. L., & Smith, T. J. (2016) · Journal of Pain · doi:10.1016/j.jpain.2016.10.020 · Cited by 69
Luz, J. G., Antonysamy, S., Kuklish, S. L., Condon, B., Lee, M. R., Allison, D., Yu, X., Chandrasekhar, S., Backer, R. T., Zhang, A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00330 · Cited by 68
N -naphthoyl-β-naltrexamine (NNTA), a highly selective and potent activator of μ/κ-opioid heteromers
Yekkirala, A. S., Lunzer, M. M., McCurdy, C. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016277108 · Cited by 68
Self-citationMediation of opioid analgesia by a truncated 6-transmembrane GPCR
Lu, Z., Xu, J., Rossi, G. C., Majumdar, S., Pasternak, G. W., & Pan, Y. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81070 · Cited by 66
Pollema‐Mays, S. L., Centeno, M. V., Ashford, C. J., Apkarian, A. V., & Martina, M. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.08.002 · Cited by 66
Padi, S. S. V., Shi, X., Zhao, Y. Q., Ruff, M. R., Baichoo, N., Pert, C. B., & Zhang, J. (2011) · Pain · doi:10.1016/j.pain.2011.09.022 · Cited by 66
Wei, H., & Pertovaara, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.064 · Cited by 66
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279
Keith, J. M., Jones, W. M., Tichenor, M. S., Liu, J., Seierstad, M. J., Palmer, J. A., Webb, M., Karbarz, M. J., Scott, B. P., Wilson, S. J., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00353 · Cited by 65
Jin, Y., Smith, C. S., Hu, L., Campanale, K. M., Stoltz, R. R., Huffman, L., McNearney, T. A., Xy, Y., Ackermann, B., Dean, R. A., et al. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.260 · Cited by 64
Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT system
Smith, S. M., Amtmann, D., Askew, R. L., Gewandter, J. S., Hunsinger, M., Jensen, M. P., McDermott, M. P., Patel, K. V., Williams, M., Bacci, E. D., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000502 · Cited by 63
Steenwinckel, J. V., Auvynet, C., Sapienza, A., Goazigo, A. R.-L., Combadière, C., & Parsadaniantz, S. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.10.016 · Cited by 62
Kalliomäki, J., Segerdahl, M., Webster, L. R., Reimfelt, A., Huizar, K., Annas, P., Karlsten, R., & Quiding, H. (2013) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2012.08.004 · Cited by 62
Murray, J. K., Long, J., Zou, A., Ligutti, J., Andrews, K. L., Poppe, L., Biswas, K., Moyer, B. D., McDonough, S. I., & Miranda, L. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01947 · Cited by 61
Stemkowski, P. L., Noh, M., Chen, Y., & Smith, P. A. (2015) · The Journal of Physiology · doi:10.1113/jp270905 · Cited by 60
Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain
Gimbel, J. S., Kivitz, A., Bramson, C., Nemeth, M. A., Keller, D. S., Brown, M. T., West, C. R., & Verburg, K. M. (2014) · Pain · doi:10.1016/j.pain.2014.06.004 · Cited by 60
Akgün, E., Javed, M. I., Lunzer, M. M., Powers, M. D., Sham, Y. Y., Watanabe, Y., & Portoghese, P. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01245 · Cited by 59
Bupivacaine‐induced cellular entry of QX ‐314 and its contribution to differential nerve block
Brenneis, C., Kistner, K., Puopolo, M., Jo, S., Roberson, D., Sisignano, M., Segal, D., Cobos, E. J., Wainger, B. J., Labocha, S., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12466 · Cited by 58
Self-citationAnand, U., Yiangou, Y., Sinisi, M., Fox, M., MacQuillan, A. H. F., Quick, T., Korchev, Y. E., Bountra, C., McCarthy, T. D., & Anand, P. (2015) · Molecular Pain · doi:10.1186/s12990-015-0038-x · Cited by 57
Opioid peptides in peripheral pain control
Leśniak, A., & Lipkowski, A. W. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1829 · Cited by 56
An industry perspective on the role and utility of animal models of pain in drug discovery
Whiteside, G. T., Pomonis, J. D., & Kennedy, J. D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.08.033 · Cited by 55
Ghosh, S., Kinsey, S. G., Liu, Q.-S., Hruba, L., McMahon, L. R., Grim, T. W., Merritt, C. R., Wise, L. E., Abdullah, R. A., Selley, D. E., et al. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.222851 · Cited by 54
Kv7 Channels as Targets for the Treatment of Pain
Wickenden, A., & McNaughton-Smith, G. A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788186326 · Cited by 53
The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray
Deliu, E., Sperow, M., Console‐Bram, L., Carter, R. L., Tilley, D. G., Kalamarides, D. J., Kirby, L. G., Brailoiu, G. C., Brailoiu, E., Benamar, K., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099333 · Cited by 52
Soluble Epoxide Hydrolase Inhibition Is Antinociceptive in a Mouse Model of Diabetic Neuropathy
Wagner, K. M., Yang, J., İnceoğlu, B., & Hammock, B. D. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.05.008 · Cited by 51
Grim, T. W., Ghosh, S., Hsu, K.-L., Cravatt, B. F., Kinsey, S. G., & Lichtman, A. H. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.07.008 · Cited by 50
Kv7.2 regulates the function of peripheral sensory neurons
King, C. H., Lancaster, E., Salomon, D., Peles, E., & Scherer, S. S. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23595 · Cited by 50
Activation of CXCL10/CXCR3 Signaling Attenuates Morphine Analgesia: Involvement of Gi Protein
Ye, D., Bu, H., Guo, G., et al. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0223-1 · Cited by 50
Pawsey, S., Wood, M., Browne, H. L., Donaldson, K. M., Christie, M. I., & Warrington, S. (2016) · Drugs in R&D · doi:10.1007/s40268-016-0127-y · Cited by 50
Src family kinases involved in CXCL12-induced loss of acute morphine analgesia
Rivat, C., Sebaihi, S., Steenwinckel, J. V., Fouquet, S., Kitabgi, P., Pohl, M., Parsadaniantz, S. M., & Goazigo, A. R.-L. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.11.010 · Cited by 49
Novel KCNQ2/Q3 Agonists as Potential Therapeutics for Epilepsy and Neuropathic Pain
Fritch, P. C., McNaughton-Smith, G. A., Amato, G. S., Burns, J. F., Eargle, C. W., Roeloffs, R., Harrison, W., Jones, L. S., & Wickenden, A. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901497b · Cited by 49
Restoring the Spinal Pain Gate
Zeilhofer, H. U., Ralvenius, W. T., & Acuña, M. A. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2014.11.007 · Cited by 49
Ostenfeld, T., Krishen, A., Lai, R. Y. K., Bullman, J., Green, J., Anand, P., Scholz, J., & Kelly, M. (2014) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000122 · Cited by 47
Wieskopf, J. S., Pan, Y., Marcovitz, J., Tuttle, A. H., Majumdar, S., Pidakala, J., Pasternak, G. W., & Mogil, J. S. (2014) · Pain · doi:10.1016/j.pain.2014.07.014 · Cited by 45
Calcium Channel CaVα1 Splice Isoforms - Tissue Specificity and Drug Action
Lipscombe, D., & Andrade, A. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150507103215 · Cited by 45
Kv7.5 is the primary Kv7 subunit expressed in C‐fibers
King, C. H., & Scherer, S. S. (2011) · The Journal of Comparative Neurology · doi:10.1002/cne.23019 · Cited by 44
Inhibitors of voltage-gated Sodium Channel Na v 1.7: Patent Applications Since 2010
Sun, S., Cohen, C. J., & Dehnhardt, C. M. (2014) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.14.39 · Cited by 43
Contributions of spinal d-amino acid oxidase to bone cancer pain
Huang, J., Chen, X., Guo, C., & Wang, Y. (2012) · Amino Acids · doi:10.1007/s00726-012-1390-z · Cited by 40
Rodrigues, N., Bennis, K., Vivier, D., Pereira, V., Chatelain, F. C., Chapuy, E., Deokar, H. S., Busserolles, J., Lesage, F., Eschalier, A., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.01.049 · Cited by 39
Singla, N., Hunsinger, M., Chang, P. D., McDermott, M., Chowdhry, A. K., Desjardins, P. J., Turk, D. C., & Dworkin, R. H. (2015) · Journal of Pain · doi:10.1016/j.jpain.2015.03.015 · Cited by 37
Aceto, M. D. G., Harris, L. S., Negus, S. S., Banks, M. L., Hughes, L. D., Akgün, E., & Portoghese, P. S. (2012) · International Journal of Medicinal Chemistry · doi:10.1155/2012/327257 · Cited by 37
Scott, V., Vortherms, T. A., Niforatos, W., Swensen, A. M., Neelands, T. R., Milicic, I., Banfor, P. N., King, A., Zhong, C., Simler, G. H., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.10.019 · Cited by 36
Heterologous expression of NaV1.9 chimeras in various cell systems
Goral, R. O., Leipold, E., Nematian-Ardestani, E., & Heinemann, S. H. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-015-1709-1 · Cited by 35
Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists
Altun, A., Yıldırım, K., Özdemir, E., Bağcıvan, İ., Gürsoy, S., & Durmuş, N. (2015) · The Journal of Physiological Sciences · doi:10.1007/s12576-015-0379-2 · Cited by 35
The Angiotensin II Type 2 Receptor for Pain Control
Danser, A. H. J., & Anand, P. (2014) · Cell · doi:10.1016/j.cell.2014.05.030 · Cited by 34
Restoring ionotropic inhibition as an analgesic strategy
Bonin, R. P., & Koninck, Y. D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.047 · Cited by 33
Marrone, G. F., Grinnell, S. G., Lu, Z., Rossi, G. C., Rouzic, V. L., Xu, J., Majumdar, S., Pan, Y., & Pasternak, G. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523894113 · Cited by 32
Klinger, F., Bajrić, M., Salzer, I., Dorostkar, M. M., Khan, D., Pollak, D. D., Kubista, H., Boehm, S., & Koenig, X. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13262 · Cited by 29
Activation of peripheral KCNQ channels relieves gout pain
Zheng, Y., Xu, H., Zhan, L., Zhou, X., Chen, X., & Gao, Z. (2015) · Pain · doi:10.1097/j.pain.0000000000000122 · Cited by 28
Kort, M. E., Atkinson, R. N., Thomas, J. B., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.121 · Cited by 28
Lyu, C., Mulder, J., Barde, S. S., Sahlholm, K., Zeberg, H., Nilsson, J., Århem, P., Hökfelt, T. G. M., Fried, K., & Shi, T.-J. S. (2015) · Molecular Pain · doi:10.1186/s12990-015-0044-z · Cited by 24
Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
Nevalainen, T. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113206660296 · Cited by 24
Two to tango: GPCR oligomers and GPCR-TRP channel interactions in nociception
Yekkirala, A. S. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.021 · Cited by 24
Self-citationChandrasekhar, S., Harvey, A. K., Yu, X., Chambers, M. G., Oskins, J. L., Lin, C., Seng, T. W., Thibodeaux, S. J., Norman, B. H., Hughes, N. E., et al. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.228932 · Cited by 24
Butt, M. T., Evans, M., Bowman, C., Cummings, T., Oneda, S., Shelton, D. L., & Zorbas, M. A. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu192 · Cited by 23
Patel, R., Rutten, K., Valdor, M., Schiene, K., Wigge, S., Schunk, S. J., Damann, N., Christoph, T., & Dickenson, A. H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.057 · Cited by 22
Manitpisitkul, P., Mayorga, A. J., Shalayda, K., Meulder, M. D., Romano, G. J., Jun, C., & Moyer, J. A. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0285-7 · Cited by 22
Wozniak, K. M., Wu, Y., Vornov, J. J., Lapidus, R. G., Rais, R., Rojas, C. J., Tsukamoto, T., & Slusher, B. S. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.197665 · Cited by 22
Quality of life in patients with rheumatoid arthritis: does abatacept make a difference?
Michaud, K. D., Bombardier, C., & Emery, P. (2007) · PubMed · Cited by 19
Zhu, C., Vortherms, T. A., Zhang, M., Xu, J. Y., Swensen, A. M., Niforatos, W., Neelands, T. R., Milicic, I., Lewis, L. G. R., Zhong, C., et al. (2013) · Journal of Pain · doi:10.1016/j.jpain.2013.12.002 · Cited by 15
Xie, F., Wang, Y., Li, X., Chao, Y.-C., & Yue, Y. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1943-8 · Cited by 15
Pain: morphine, metabolites, mambas, and mutations
Woolf, C. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70287-9 · Cited by 14
Self-citationAbuse-Deterrent Opioid Formulations
Kunins, H. V. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0939 · Cited by 14
Xu, J., Chu, K. L., Zhu, C., Niforatos, W., Swensen, A. M., Searle, X. B., Lee, L., Jarvis, M. F., & McGaraughty, S. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00463.2013 · Cited by 13
Wu, Y., Conway, C. M., Sun, L., Machet, F., Chen, J., Chen, P., He, H., Bourin, C., Calandra, V., Polino, J. L., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.092 · Cited by 12
Christianson, C. A., Fitzsimmons, B., Shim, J., Agrawal, A., Cohen, S. M., Hua, X.-Y., & Yaksh, T. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.019 · Cited by 11
Cited by
Neuroinflammation and Central Sensitization in Chronic and Widespread Pain
Ji, R.-R., Nackley, A., Huh, Y., Terrando, N., & Maixner, W. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002130 · Cited by 1,630
Etiology and Pharmacology of Neuropathic Pain
Alles, S. R. A., & Smith, P. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014399 · Cited by 395
Cellular Circuits in the Brain and Their Modulation in Acute and Chronic Pain
Kuner, R., & Kuner, T. (2021) · Physiological Reviews · doi:10.1152/physrev.00040.2019 · Cited by 343
Microglia Are Indispensable for Synaptic Plasticity in the Spinal Dorsal Horn and Chronic Pain
Zhou, L.-J., Peng, J., Xu, Y.-N., Zeng, W.-J., Zhang, J., Wei, X., Mai, C.-L., Lin, Z.-J., Liu, Y., Murugan, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.087 · Cited by 228
State-Dependent Inhibition of Nav1.8 Sodium Channels by VX-150 and VX-548
Vaelli, P., Fujita, A., Jo, S., Zhang, H.-X. B., Osorno, T., Ma, X., & Bean, B. P. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000944 · Cited by 58
Self-citation
Metadata
- Authors
- Yekkirala, A. S., Roberson, D. P., Bean, B. P., & Woolf, C. J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2017-06-09
- Volume
- 16
- Issue
- 8
- Pages
- 545-564
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2621496977
- Cited by
- 364
- References
- 266
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.